Aktis Oncology (AKTS) Stock Price Target 2026

The average analyst price target for Aktis Oncology is $31.50, 92.4% above the current price. Of 9 analysts, 8 rate it Buy and 1 Hold. Targets range from $1 to $40. The latest change came on Sep 9, 2026, when Oppenheimer initiated coverage of Aktis Oncology with an Outperform rating and a $40 price target.